LD-2 disclosure · 2nd Quarter - Report
MEDICINES FOR MALARIA VENTURE
Client
- Description
- Not-for-profit public-private partnership/R&D and Delivery of Malaria Medicines
- Location
- Switzerland
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011, USAID and Malaria research and development issues and initiatives. Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011, USAID and Malaria research and development issues and initiatives. Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2012, USAID and Malaria research and development issues and initiatives. Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2012, USAID and Malaria research and development issues and initiatives.
LobbyistsMARK TAVLARIDES · H STEWART VAN SCOYOC · GREG VAN SCOYOC · EDWARD LONG
TargetedSENATE · HOUSE OF REPRESENTATIVES · Natl Institutes of Health (NIH) · U.S. Agency for International Development (USAID)
Medical/Disease Research/Clinical Labs
USAID and Malaria research and development issues and initiatives
LobbyistsMARK TAVLARIDES · H STEWART VAN SCOYOC · GREG VAN SCOYOC · EDWARD LONG
TargetedSENATE · HOUSE OF REPRESENTATIVES · Natl Institutes of Health (NIH) · U.S. Agency for International Development (USAID)